Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
Clinical trial NCT04716686 · RECRUITING
Trial details
- NCT number
- NCT04716686
- Sponsor
- Shandong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-12-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.